GE HealthCare Technologies (GEHC) Other Non-Current Liabilities (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Other Non-Current Liabilities came in at $2.1 billion in Q2 2026, up 6.38% YoY from $2.0 billion in Q2 2025, and up 5.86% on a QoQ basis from $2.0 billion in Q1 2026.
GE HealthCare Technologies (GEHC) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Other Non-Current Liabilities data on file, last reported at $2.1 billion in Q2 2026.
- Quarterly Other Non-Current Liabilities rose 6.38% year-over-year to $2.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.1 billion (up 6.38% YoY) and the FY2025 annual result came in at $2.1 billion, up 14.76% from the prior year.
- Other Non-Current Liabilities advanced to $2.1 billion in Q2 2026, from $2.0 billion in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $2.1 billion in Q2 2026 to a low of $1.6 billion in Q4 2022.
- A 5-year average of $1.9 billion and a median of $1.9 billion in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities advanced 17.09% — and 2024, when it dropped 6.75%.
- Tracing GEHC's Other Non-Current Liabilities over 5 years: stood at $1.6 billion in 2022, then increased by 17.09% to $1.9 billion in 2023, then retreated by 4.32% to $1.8 billion in 2024, then climbed by 14.76% to $2.1 billion in 2025, then rose by 3.49% to $2.1 billion in 2026.
- The last three Other Non-Current Liabilities figures came in at $2.1 billion (Q2 2026), $2.0 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.13 Bn |
| Mar 31, 2026 | 2.02 Bn |
| Dec 31, 2025 | 2.06 Bn |
| Sep 30, 2025 | 2.10 Bn |
| Jun 30, 2025 | 2.01 Bn |
| Mar 31, 2025 | 1.84 Bn |
| Dec 31, 2024 | 1.80 Bn |
| Sep 30, 2024 | 1.92 Bn |
| Jun 30, 2024 | 1.80 Bn |
| Mar 31, 2024 | 1.81 Bn |
| Dec 31, 2023 | 1.88 Bn |
| Sep 30, 2023 | 1.83 Bn |
| Jun 30, 2023 | 1.93 Bn |
| Mar 31, 2023 | 1.83 Bn |
| Dec 31, 2022 | 1.60 Bn |